Clinical Trials Browser

Nebivolol × Clear all

NCT07233499 2025-11-19

Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

Phase 2 Recruiting

Breast Neoplasms

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity